Published in Mayo Clin Proc on April 01, 1985
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother (1986) 4.51
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother (1987) 3.49
New directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrob Agents Chemother (1989) 2.63
Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965). J Clin Microbiol (1986) 1.93
Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob Agents Chemother (1995) 1.54
The future of new oral antibiotics including the quinolones. CMAJ (1988) 1.22
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1987) 1.18
In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother (1993) 1.01
Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin. Antimicrob Agents Chemother (1991) 0.99
In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics. Antimicrob Agents Chemother (1990) 0.96
Antivirulence activity of azithromycin in Pseudomonas aeruginosa. Front Microbiol (2014) 0.90
More macrolides. BMJ (1991) 0.90
Allergy to antibiotics in children: Perception versus reality. Paediatr Child Health (2002) 0.75
Allergy to antibiotics in children: Perception versus reality. Can J Infect Dis (2002) 0.75
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
Comparison of two commercially available media for detection of bacteremia. Appl Microbiol (1971) 11.61
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Antimicrob Agents Chemother (1977) 7.14
Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc (1975) 7.01
Blood cultures: issues and controversies. Rev Infect Dis (1986) 6.95
Radiometric method for detection of bacteremia. Appl Microbiol (1971) 6.77
Evaluation of radiometric system for detecting bacteremia. Appl Microbiol (1973) 6.26
Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99
Effects of atmosphere of incubation and of routine subcultures on detection of bacteremia in vacuum blood culture bottles. J Clin Microbiol (1975) 5.78
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Multi-laboratory evaluation of an automated microbial detection/identification system. J Clin Microbiol (1978) 5.74
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol (1978) 5.07
Blood cultures: principles and techniques. Mayo Clin Proc (1975) 4.87
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Effect of volume of blood cultured on detection of bacteremia. J Clin Microbiol (1976) 4.75
Comparison of two liquid blood culture media containing sodium polyanethole sulfonate: tryptic soy and Columbia. Appl Microbiol (1974) 4.52
Detection of bacteremia with liquid media containing sodium polyanetholsulfonate. Appl Microbiol (1974) 4.41
Clinical laboratory evaluation of automated microbial detection/identification system in analysis of clinical urine specimens. J Clin Microbiol (1979) 4.12
Evaluation of the necessity for routine terminal subcultures of previously negative blood cultures. J Clin Microbiol (1980) 4.08
The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis (1983) 4.05
Detection of fungi in blood cultures. J Clin Microbiol (1975) 4.05
Evaluation of two commercially available media for detection of bacteremia. Appl Microbiol (1972) 3.77
Recovery of yeast from vented blood culture bottles. J Clin Microbiol (1975) 3.42
Laboratory approaches to the identification of Enterobacteriaceae. Hum Pathol (1976) 3.30
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
Evaluation of a biphasic medium for blood cultures. J Clin Microbiol (1979) 3.23
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol (1989) 2.96
Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am (1977) 2.94
Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis (1987) 2.93
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol (1980) 2.93
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
Evaluation of blood culture media supplemented with sucrose or with cysteine. J Clin Microbiol (1975) 2.81
The in vitro spectrum of the cephalosporins. Mayo Clin Proc (1976) 2.72
Microbiological study of streptococcal bacteremia. Appl Microbiol (1973) 2.70
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis (1991) 2.65
Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates. Antimicrob Agents Chemother (1974) 2.65
Coryneform bacterial endocarditis: difficulties in diagnosis and treatment, presentation of three cases, and review of literature. Mayo Clin Proc (1977) 2.63
Evaluation of the modified Micro-ID system for identification of Enterobacteriaceae. J Clin Microbiol (1979) 2.61
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Vaginal flora in asymptomatic women. Mayo Clin Proc (1976) 2.49
Evaluation of a routine anaerobic subculture of blood cultures for detection of anaerobic bacteremia. J Clin Microbiol (1978) 2.44
Comparison of recovery of organisms from blood cultures diluted 10% (volume/volume) and 20% (volume/volume). J Clin Microbiol (1982) 2.42
Antimicrobial susceptibility of enterobacteriaceae and nonfermenting gram-negative bacilli. Mayo Clin Proc (1969) 2.41
Polymicrobial bacteremia. Ann Intern Med (1970) 2.40
The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol (1982) 2.40
Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis (1979) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
Comparison of direct and standardized antimicrobial susceptibility testing of positive blood cultures. Antimicrob Agents Chemother (1976) 2.30
Controlled clinical evaluation of BACTEC Plus Aerobic/F and BacT/Alert Aerobic FAN bottles for detection of bloodstream infections. J Clin Microbiol (1995) 2.25
Optimal time for routine early subculture of blood cultures. J Clin Microbiol (1980) 2.24
Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J Clin Microbiol (1996) 2.23
Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis (1997) 2.17
Retrospective comparison of three blood culture media for the recovery of yeasts from clinical specimens. Eur J Clin Microbiol (1983) 2.15
Comparison of lysis-centrifugation with a biphasic blood culture medium for the recovery of aerobic and facultatively anaerobic bacteria. J Clin Microbiol (1984) 2.15
N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization. J Med Chem (1999) 2.13
Infections due to group C streptococci in man. Am J Med (1979) 2.08
Controlled clinical evaluation of Isolator and ESP aerobic blood culture systems for detection of bloodstream infections. J Clin Microbiol (1994) 2.07
Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob Agents Chemother (1978) 2.07
Unclassified, lactose-fermenting, urease-producing member of the family Enterobacteriaceae resembling Escherichia coli. J Clin Microbiol (1975) 2.07
Evaluation of media for isolation of Campylobacter fetus subsp. jejuni from fecal specimens. J Clin Microbiol (1981) 2.04
Infective endocarditis caused by HACEK microorganisms. Annu Rev Med (1997) 2.03
Effect of preoperative antibiotic regimen on development of infection after intestinal surgery: Prospective, randomized, double-blind study. Ann Surg (1974) 2.03
Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00
The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med (1996) 2.00
Spurious ampicillin resistance by testing Haemophilus influenzae with agar containing supplement C. Antimicrob Agents Chemother (1976) 1.99
Prospective evaluation of the risk of bacteremia associated with transesophageal echocardiography. Circulation (1991) 1.99
Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. JAMA (1992) 1.97
Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med (1990) 1.96
Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258) J Med Chem (1994) 1.93
G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci (1999) 1.92
Comparison of the Roche Septi-Chek blood culture bottle with a brain heart infusion biphasic medium bottle and with a tryptic soy broth bottle. J Clin Microbiol (1984) 1.92
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). Mayo Clin Proc (1985) 1.91
Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin. Antimicrob Agents Chemother (1973) 1.91
Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. J Clin Invest (1975) 1.91
Inhibitory effects of vancomycin on Neisseria gonorrhoeae in Thayer-Martin medium. J Infect Dis (1980) 1.89
Comparison of three blood culture media with tryptic soy broth. J Clin Microbiol (1978) 1.88
Diarrhea due to Campylobacter fetus subspecies jejuni. A clinical review of 63 cases. Mayo Clin Proc (1981) 1.88
Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87
Streptococcus mutans endocarditis. Ann Intern Med (1974) 1.86
Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80
Controlled clinical comparison of Isolator and BACTEC 9240 Aerobic/F resin bottle for detection of bloodstream infections. J Clin Microbiol (1995) 1.80
Hydrogen sulfide-producing variants of Escherichia coli. Appl Microbiol (1974) 1.79